George Ricaurte

Research output

Research output per year 1980 1987 1988 1989 1992 1993 1994 1997 1998 1999 2000 2001 2002 2004 2007 2009 2018

• 149 Article
• 10 Letter
• 7 Comment/debate
• 7 Review article
• 13 More
  • 4 Chapter
  • 4 Short survey
  • 3 Editorial
  • 2 Conference contribution

Research output per year

Research output per year

Search results

• 2018

  Pharmacokinetic and pharmacodynamic analysis of d-amphetamine in an attention task in rodents

  Slezak, J. M., Mueller, M., Ricaurte, G. A. & Katz, J. L., Sep 1 2018, In: Behavioural Pharmacology. 29, 6, p. 551-556 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Dextroamphetamine 100%
  • Rodentia 64%
  • Attention Deficit Disorder with Hyperactivity 59%
  • Pharmacokinetics 58%
  • Amphetamine 21%
  2 Scopus citations
• 2014

  Acquisition of MDMA self-administration: Pharmacokinetic factors and MDMA-induced serotonin release

  Bradbury, S., Bird, J., Colussi-Mas, J., Mueller, M., Ricaurte, G. & Schenk, S., Sep 2014, In: Addiction Biology. 19, 5, p. 874-884 11 p.

  Research output: Contribution to journal › Article › peer-review

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Self Administration 88%
  • Serotonin 63%
  • Pharmacokinetics 56%
  • Cocaine 15%
  31 Scopus citations

• Methylphenidate and impulsivity: A comparison of effects of methylphenidate enantiomers on delay discounting in rats

  Slezak, J. M., Ricaurte, G. A., Tallarida, R. J. & Katz, J. L., Jan 2014, In: Psychopharmacology. 231, 1, p. 191-198 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Delay Discounting 100%
  • Methylphenidate 85%
  • Impulsive Behavior 77%
  • Area Under Curve 12%
  • Attention Deficit Disorder with Hyperactivity 7%
  13 Scopus citations
• 2013

  Behavioral effects and pharmacokinetics of (6)-3,4- methylenedioxymethamphetamine (MDMA, ecstasy) after intragastric administration to baboons

  Goodwin, A. K., Mueller, M., Shell, C. D., Ricaurte, G. A. & Ator, N. A., Jun 2013, In: Journal of Pharmacology and Experimental Therapeutics. 345, 3, p. 342-353 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Papio 91%
  • Pharmacokinetics 56%
  • alpha-methylepinine 8%
  • Catheters 6%
  4 Scopus citations

• Effects of MDMA on the Human Nervous System

  McCann, U. D. & Ricaurte, G. A., Dec 2013, The Effects of Drug Abuse on the Human Nervous System. Elsevier Inc., p. 475-497 23 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Nervous System 60%
  • Serotonin 25%
  • Hallucinogens 10%
  • Neurotoxins 8%
  5 Scopus citations

• Single oral doses of (±) 3,4-methylenedioxymethamphetamine ('Ecstasy') produce lasting serotonergic deficits in non-human primates: Relationship to plasma drug and metabolite concentrations

  Mueller, M., Yuan, J., McCann, U. D., Hatzidimitriou, G. & Ricaurte, G. A., May 2013, In: International Journal of Neuropsychopharmacology. 16, 4, p. 791-801 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Primates 69%
  • Pharmaceutical Preparations 30%
  • Saimiri 12%
  • Serotonin 11%
  7 Scopus citations

• Studies of (±)-3,4-methylenedioxymethamphetamine (mdma) metabolism and disposition in rats and mice: Relationship to neuroprotection and neurotoxicity profile

  Mueller, M., Maldonado-Adrian, C., Yuan, J., McCann, U. D. & Ricaurte, G. A., Feb 2013, In: Journal of Pharmacology and Experimental Therapeutics. 344, 2, p. 479-488 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Neuroprotection 78%
  • Hypothermia 20%
  • alpha-methylepinine 10%
  • 4-hydroxy-3-methoxymethamphetamine 10%
  17 Scopus citations
• 2011

  Altered pain responses in abstinent (±)3,4- methylenedioxymethamphetamine (MDMA, "ecstasy") users

  Mccann, U. D., Edwards, R. R., Smith, M. T., Kelley, K., Wilson, M., Sgambati, F. & Ricaurte, G., Oct 2011, In: Psychopharmacology. 217, 4, p. 475-484 10 p.

  Research output: Contribution to journal › Article › peer-review

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Pain 42%
  • Sleep 41%
  • Pain Perception 25%
  • Serotonin 18%
  8 Scopus citations

• Identifying the serotonin transporter signal in Western blot studies of the neurotoxic potential of MDMA and related drugs

  Mclane, M. W., Mccann, U. & Ricaurte, G., Dec 2011, In: Synapse. 65, 12, p. 1368-1372 5 p.

  Research output: Contribution to journal › Article › peer-review

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Serotonin Plasma Membrane Transport Proteins 92%
  • Western Blotting 50%
  • Pharmaceutical Preparations 30%
  • Proteins 18%
  7 Scopus citations

• Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: Implications for mechanisms of neurotoxicity

  Mueller, M., Yuan, J., Maldonado Adrian, C., Mccann, U. D. & Ricaurte, G. A., Oct 2011, In: Synapse. 65, 10, p. 983-990 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • alpha-methylepinine 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 64%
  • Serotonin 41%
  • Dextromethorphan 30%
  • catechol 14%
  7 Scopus citations

• Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: Comparison with humans reveals marked differences

  Mueller, M., Goodwin, A. K., Ator, N. A., McCann, U. D. & Ricaurte, G. A., Jul 2011, In: Journal of Pharmacology and Experimental Therapeutics. 338, 1, p. 310-317 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Papio 91%
  • Oral Administration 64%
  • Pharmacokinetics 15%
  • alpha-methylepinine 8%
  11 Scopus citations

• Synthesis and neurotoxicity profile of 2,4,5-trihydroxymethamphetamine and its 6-(N-acetylcystein-S-yl) conjugate

  Neudörffer, A., Mueller, M., Martinez, C. M., Mechan, A., McCann, U., Ricaurte, G. A. & Largeron, M., Jun 20 2011, In: Chemical research in toxicology. 24, 6, p. 968-978 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • 6-(N-acetylcystein-S-yl)-2,4,5-trihydroxymethamphetamine 100%
  • Neurotoxic 49%
  • Neurotoxicity 48%
  • Marker 33%
  • Serotonin 33%
  2 Scopus citations
• 2010

  Dopamine is not essential for the development of methamphetamine-induced neurotoxicity

  Yuan, J., Darvas, M., Sotak, B., Hatzidimitriou, G., McCann, U. D., Palmiter, R. D. & Ricaurte, G. A., Aug 2010, In: Journal of Neurochemistry. 114, 4, p. 1135-1142 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Neurotoxicity 100%
  • Methamphetamine 93%
  • Dopamine 74%
  • Synaptic Transmission 28%
  • Brain 24%
  12 Scopus citations
• 2009

  Direct comparison of (±) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans

  Mueller, M., Kolbrich, E. A., Peters, F. T., Maurer, H. H., McCann, U. D., Huestis, M. A. & Ricaurte, G. A., Jun 2009, In: Therapeutic drug monitoring. 31, 3, p. 367-373 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Saimiri 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 97%
  • alpha-methylepinine 30%
  • 4-hydroxy-3-methoxymethamphetamine 29%
  • 3,4-Methylenedioxyamphetamine 26%
  18 Scopus citations

• Further studies on the role of metabolites in (±)-3,4- methylenedioxymethamphetamine-induced serotonergic neurotoxicity

  Mueller, M., Yuan, J., Felim, A., Neudörffer, A., Peters, F. T., Maurer, H. H., McCann, U. D., Largeron, M. & Ricaurte, G. A., Oct 2009, In: Drug Metabolism and Disposition. 37, 10, p. 2079-2086 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • 4-hydroxy-3-methoxymethamphetamine 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 84%
  • Neurotoxicity 78%
  • Intraparenchymal 25%
  • Serotonin 23%
  50 Scopus citations

• Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma

  Mueller, M., Kolbrich-Spargo, E. A., Peters, F. T., Huestis, M. A., Ricaurte, G. A. & Maurer, H. H., Mar 2009, In: Analytical and Bioanalytical Chemistry. 393, 6-7, p. 1607-1617 11 p.

  Research output: Contribution to journal › Article › peer-review

  • 3,4-methylenedioxymethamphetamine 100%
  • Saimiri 89%
  • N-Methyl-3,4-methylenedioxyamphetamine 88%
  • Hydrolysis 60%
  • Cleavage 44%
  13 Scopus citations

• Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage

  Mueller, M., Peters, F. T., Huestis, M. A., Ricaurte, G. A. & Maurer, H. H., Jan 30 2009, In: Forensic Science International. 184, 1-3, p. 64-68 5 p.

  Research output: Contribution to journal › Article › peer-review

  • alpha-methylepinine 100%
  • 4-hydroxy-3-methoxymethamphetamine 99%
  • 3,4-Methylenedioxyamphetamine 86%
  • Saimiri 66%
  • N-Methyl-3,4-methylenedioxyamphetamine 64%
  15 Scopus citations

• Sleep apnea in young abstinent recreational MDMA ("ecstasy") consumers

  McCann, U. D., Sgambati, F. P., Schwartz, A. R. & Ricaurte, G. A., Dec 2009, In: Neurology. 73, 23, p. 2011-2017 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Sleep Apnea Syndromes 80%
  • Obstructive Sleep Apnea 42%
  • Serotonin 21%
  • Apnea 17%
  37 Scopus citations

• Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("ecstasy") users

  McCann, U. D., Wilson, M. J., Sgambati, F. P. & Ricaurte, G. A., Nov 4 2009, In: Journal of Neuroscience. 29, 44, p. 14050-14056 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Sleep Deprivation 87%
  • Sleep 31%
  • Serotonin 23%
  • Short-Term Memory 12%
  10 Scopus citations
• 2008

  Liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain

  Mueller, M., Peters, F. T., Ricaurte, G. A. & Maurer, H. H., Oct 15 2008, In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 874, 1-2, p. 119-124 6 p.

  Research output: Contribution to journal › Article › peer-review

  • alpha-methylepinine 100%
  • 4-hydroxy-3-methoxymethamphetamine 99%
  • 3,4-Methylenedioxyamphetamine 86%
  • 3,4-methylenedioxymethamphetamine 73%
  • N-Methyl-3,4-methylenedioxyamphetamine 64%
  10 Scopus citations

• Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines (Neuropsychopharmacology (2006) 31, (2639-2651) DOI: 10.1038/sj.npp.1301031)

  Xie, T., Tong, L., McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. & Ricaurte, G., Feb 2008, In: Neuropsychopharmacology. 33, 3, p. 712-713 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Nonlinear pharmacokinetics of (±)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses

  Mueller, M., Peters, F. T., Maurer, H. H., McCann, U. D. & Ricaurte, G. A., Oct 2008, In: Journal of Pharmacology and Experimental Therapeutics. 327, 1, p. 38-44 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Saimiri 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 97%
  • Pharmacokinetics 54%
  • alpha-methylepinine 8%
  • 4-hydroxy-3-methoxymethamphetamine 8%
  28 Scopus citations

• Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users

  McCann, U. D., Kuwabara, H., Kumar, A., Palermo, M., Abbey, R., Brasic, J., Ye, W., Alexander, M., Dannals, R. F., Wong, D. F. & Ricaurte, G. A., Feb 2008, In: Synapse. 62, 2, p. 91-100 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Dopamine Plasma Membrane Transport Proteins 100%
  • Methamphetamine 95%
  • Executive Function 25%
  • Serotonin 20%
  • Memory Disorders 17%
  146 Scopus citations

• Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine ("ecstasy") users: Relationship to cognitive performance

  McCann, U. D., Szabo, Z., Vranesic, M., Palermo, M., Mathews, W. B., Ravert, H. T., Dannals, R. F. & Ricaurte, G. A., Oct 2008, In: Psychopharmacology. 200, 3, p. 439-450 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Serotonin Plasma Membrane Transport Proteins 92%
  • Dopamine Plasma Membrane Transport Proteins 91%
  • Electrons 59%
  • Brain 36%
  116 Scopus citations
• 2007

  Effects of (±) 3,4-methylenedioxymethamphetamine (MDMA) on sleep and circadian rhythms

  McCann, U. D. & Ricaurte, G. A., Nov 2 2007, In: TheScientificWorldJournal. 7, SUPPL. 2, p. 231-238 8 p.

  Research output: Contribution to journal › Short survey › peer-review

  Open Access

  • 3,4-methylenedioxymethamphetamine 100%
  • circadian rhythm 88%
  • N-Methyl-3,4-methylenedioxyamphetamine 88%
  • sleep 81%
  • Circadian Rhythm 69%
  43 Scopus citations

• Effects of MDMA on blood glucose levels and brain glucose metabolism

  Soto-Montenegro, M. L., Vaquero, J. J., Arango, C., Ricaurte, G., García-Barreno, P. & Desco, M., Jun 2007, In: European Journal of Nuclear Medicine and Molecular Imaging. 34, 6, p. 916-925 10 p.

  Research output: Contribution to journal › Article › peer-review

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Blood Glucose 61%
  • Glucose 46%
  • Brain 36%
  • Limbic System 18%
  9 Scopus citations

• Heating induces aggregation and decreases detection of serotonin transporter protein on western blots

  McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. & Ricaurte, G., Oct 2007, In: Synapse. 61, 10, p. 875-876 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Serotonin Plasma Membrane Transport Proteins 100%
  • Heating 85%
  • Western Blotting 54%
  • Hot Temperature 30%
  • Proteins 29%
  9 Scopus citations

• Neuropsychiatric Complications of Substance Abuse

  Ricaurte, G. A., Langston, J. W. & McCann, U. D., Dec 17 2007, Neurology and General Medicine: Expert Consult. Elsevier, p. 735-747 13 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Quantitative positron emission tomography studies of the serotonin transporter in humans previously treated with the appetite suppressants fenfluramine or dexfenfluramine

  McCann, U. D., Szabo, Z., Vranesic, M., Seckin, E., Wand, G., DuVal, A., Dannals, R. F. & Ricaurte, G. A., May 2007, In: Molecular Imaging and Biology. 9, 3, p. 151-157 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Dexfenfluramine 100%
  • Fenfluramine 87%
  • Appetite Depressants 82%
  • Serotonin Plasma Membrane Transport Proteins 77%
  • Positron-Emission Tomography 57%
  6 Scopus citations

• The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users

  McCann, U. D., Peterson, S. C. & Ricaurte, G. A., Aug 2007, In: Neuropsychopharmacology. 32, 8, p. 1695-1706 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • alpha-Methyltyrosine 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 94%
  • Catecholamines 65%
  • Sleep 54%
  • Impulsive Behavior 28%
  27 Scopus citations

• Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in squirrel monkey plasma

  Mueller, M., Peters, F. T., Ricaurte, G. A. & Maurer, H. H., Aug 15 2007, In: Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 855, 2 SPEC. ISS., p. 262-270 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • alpha-methylepinine 100%
  • 4-hydroxy-3-methoxymethamphetamine 99%
  • 3,4-Methylenedioxyamphetamine 86%
  • 3,4-methylenedioxymethamphetamine 73%
  • Saimiri 66%
  20 Scopus citations
• 2006

  Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines

  Xie, T., Tong, L., McLane, M. W., Hatzidimitriou, G., Yuan, J., McCann, U. & Ricaurte, G., Dec 4 2006, In: Neuropsychopharmacology. 31, 12, p. 2639-2651 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Amphetamines 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 99%
  • Serotonin Plasma Membrane Transport Proteins 92%
  • 5,7-Dihydroxytryptamine 33%
  • Serotonin 31%
  73 Scopus citations

• Overdose and withdrawal in drug abuse

  Ricaurte, G. A. & McCann, U. D., 2006, Current Therapy in Neurologic Disease. Mosby Inc., p. 346-352 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: Relationship to lasting effects on brain serotonin neurons

  Mechan, A., Yuan, J., Hatzidimitriou, G., Irvine, R. J., McCann, U. D. & Ricaurte, G. A., Feb 2006, In: Neuropsychopharmacology. 31, 2, p. 339-350 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Saimiri 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 97%
  • Serotonin 62%
  • Pharmacokinetics 54%
  • Neurons 44%
  50 Scopus citations

• Relationship between temperature, dopaminergic neurotoxicity, and plasma drug concentrations in methamphetamine-treated squirrel monkeys

  Yuan, J., Hatzidimitriou, G., Suthar, P., Mueller, M., McCann, U. & Ricaurte, G., Mar 2006, In: Journal of Pharmacology and Experimental Therapeutics. 316, 3, p. 1210-1218 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Saimiri 100%
  • Methamphetamine 85%
  • Temperature 52%
  • Pharmaceutical Preparations 30%
  • Amphetamine 23%
  39 Scopus citations

• Retraction notice to "MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: Effects on serotonin transporter densities" [Eur. J. Pharmacol. 453 (2002) 239-244] (DOI:10.1016/S0014-2999(02)02420-2)

  Boot, B. P., Mechan, A. O., McCann, U. D. & Ricaurte, G. A., Dec 28 2006, In: European Journal of Pharmacology. 553, 1-3, p. 304 1 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
  1 Scopus citations
• 2005

  Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates

  Ricaurte, G. A., Mechan, A. O., Yuan, J., Hatzidimitriou, G., Xie, T., Mayne, A. H. & McCann, U. D., Oct 2005, In: Journal of Pharmacology and Experimental Therapeutics. 315, 1, p. 91-98 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Nerve Endings 100%
  • Amphetamine 90%
  • Attention Deficit Disorder with Hyperactivity 83%
  • Primates 77%
  • Child 14%
  52 Scopus citations

• Overdose and Withdrawal in Drug Abuse

  Ricaurte, G. A. & McCann, U. D., Dec 21 2005, Current Therapy in Neurologic Disease: Text with CD-ROM. Elsevier, p. 346-352 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Quantitative PET studies of the serotonin transporter in MDMA users and controls using [¹¹C]McN5652 and [¹¹C]DASB

  McCann, U. D., Szabo, Z., Seckin, E., Rosenblatt, P., Mathews, W. B., Ravert, H. T., Dannals, R. F. & Ricaurte, G. A., Sep 2005, In: Neuropsychopharmacology. 30, 9, p. 1741-1750 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile 100%
  • N-Methyl-3,4-methylenedioxyamphetamine 74%
  • Serotonin Plasma Membrane Transport Proteins 69%
  • Positron-Emission Tomography 51%
  • Serotonin 17%
  171 Scopus citations

• Recognition and management of complications of new recreational drug use

  Ricaurte, G. A. & McCann, U. D., Jun 18 2005, In: Lancet. 365, 9477, p. 2137-2145 9 p.

  Research output: Contribution to journal › Review article › peer-review

  • Illicit Drugs 100%
  • 1,4-butanediol 39%
  • Hydroxybutyrates 35%
  • Flunitrazepam 31%
  • Ephedrine 30%
  112 Scopus citations
• 2004

  Amphetamine neurotoxicity: Accomplishments and remaining challenges

  McCann, U. D. & Ricaurte, G. A., Jan 2004, In: Neuroscience and Biobehavioral Reviews. 27, 8, p. 821-826 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Amphetamine-Related Disorders 100%
  • Methamphetamine 72%
  • Amphetamine 67%
  • History 46%
  • Brain 30%
  117 Scopus citations

• Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys

  Fantegrossi, W. E., Woolverton, W. L., Kilbourn, M., Sherman, P., Yuan, J., Hatzidimitriou, G., Ricaurte, G. A., Woods, J. H. & Winger, G., Jul 2004, In: Neuropsychopharmacology. 29, 7, p. 1270-1281 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Self Administration 88%
  • Macaca mulatta 78%
  • Intravenous Administration 70%
  • Vesicular Monoamine Transport Proteins 40%
  84 Scopus citations

• Identification and characterization of metallothionein-1 and -2 gene expression in the context of (±)3,4-methylenedioxymethamphetamine-induced toxicity to brain dopaminergic neurons

  Xie, T., Tong, L., McCann, U. D., Yuan, J., Becker, K. G., Mechan, A. O., Cheadle, C., Donovan, D. M. & Ricaurte, G. A., Aug 11 2004, In: Journal of Neuroscience. 24, 32, p. 7043-7050 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Metallothionein 92%
  • Dopaminergic Neurons 77%
  • Gene Expression 44%
  • Brain 36%
  33 Scopus citations

• MDMA- and p-chlorophenylalanine-induced reduction in 5-HT concentrations: Effects on serotonin transporter densities

  Boot, B. P., Mechan, A. O., McCann, U. D. & Ricaurte, G. A., Apr 5 2004, In: European Journal of Pharmacology. 489, 1-2, p. 1 1 p.

  Research output: Contribution to journal › Editorial › peer-review
  1 Scopus citations

• MDMA and the loss of reinforcement in Fantegrossi et al (2004) (multiple letters)

  Parrott, A. C., Fantegrossi, W. E., Woods, J. H., Winger, G., Kilbourn, M., Sherman, P., Woolverton, W. L., Yuan, J., Hatzidimitriou, G. & Ricaurte, G. A., Oct 2004, In: Neuropsychopharmacology. 29, 10, p. 1940-1942 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  2 Scopus citations

• Reply: Mdma and the loss of reinforcement in fantegrossi et al (2004)

  Fantegrossi, W. E., Woods, J. H., Winger, G., Kilbourn, M., Sherman, P., Woolverton, W. L., Yuan, J., Hatzidimitriou, G. & Ricaurte, G. A., Oct 2004, In: Neuropsychopharmacology. 29, 10, p. 1942 1 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
• 2003

  MDMA ("ecstasy") and neurotoxicity [2] (multiple letters)

  Mithoefer, M., Jerome, L., Doblin, R., Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J. & McCann, U. D., Jun 6 2003, In: Science. 300, 5625, p. 1504-1505 2 p.

  Research output: Contribution to journal › Letter › peer-review
  12 Scopus citations

• Neuroimagen y neurotoxicidad inducida por MDMA (éxtasis)

  Translated title of the contribution: Neuroimaging MDMA-induced neurotoxicityMcCann, U. D. & Ricaurte, G. A., 2003, In: Adicciones. 15, SUPPL. 2, p. 111-120 10 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • N-Methyl-3,4-methylenedioxyamphetamine 100%
  • Primates 69%
  • Neuroimaging 67%
  • Diffusion Magnetic Resonance Imaging 43%
  • Single-Photon Emission-Computed Tomography 37%
  1 Scopus citations

• Positron emission tomography of striatal serotonin transporters in Parkinson disease

  Kerenyi, L., Ricaurte, G. A., Schretlen, D. J., McCann, U., Varga, J., Mathews, W. B., Ravert, H. T., Dannals, R. F., Hilton, J., Wong, D. F. & Szabo, Z., Sep 1 2003, In: Archives of neurology. 60, 9, p. 1223-1229 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Parkinson's Disease 100%
  • Positron Emission Tomography 89%
  • Serotonin Plasma Membrane Transport Proteins 70%
  • Corpus Striatum 55%
  • Positron-Emission Tomography 52%
  114 Scopus citations

• Response to O'Shea and Colado: The MDMA neurotoxicity profile might provide clues to mechanisms

  Ricaurte, G. A., Yuan, J., Hatzidimitriou, G., Cord, B. J. & McCann, U. D., Jun 1 2003, In: Trends in Pharmacological Sciences. 24, 6, p. 275 1 p.

  Research output: Contribution to journal › Short survey › peer-review
  4 Scopus citations